Strata Critical Medical Inc (SRTA) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Strata Critical Medical Inc   (NASDAQ: SRTA)


Strata Critical Medical Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Strata Critical Medical Inc 's ROA in the second quarter of 2026?
Strata Critical Medical Inc achieved a return on average assets (ROA) of 12.13 % in its second quarter of 2026, this is above SRTA's average return on assets of 0.05%.
Strata Critical Medical Inc assets over the 12 months ending in its second quarter of 2026 are valued at $331 million

ROA decreased relative to the period ending Mar 31 2026, due to the decline in net income.

However, within the Healthcare sector 78 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 351, from total ROA ranking in the first quarter of 2026 at 434.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 72.35 % 106.99 % 22.1 % 127.32 % 34.73 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 40 47 41 40 -19
Return On Assets (TTM) 12.13 % 15.88 % 16.3 % 16.91 % -9.88 %
SRTA's Total Ranking # 351 # 434 # 361 # 3161 # 3313
Total Assets (TTM) in million 338 328 325 334 196
Seq. Total Assets Change 3.29 % 0.66 % -2.67 % 70.31 % 24.06 %
Seq. Net Income Change - - - - -

SRTA's 5 Years Annual ROA >> Back to SRTA Management Effectiveness >> Compare SRTA ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 19
Sector # 79
Overall # 478

Return On Assets Statistics
High Average Low
84.78 %
0.05 %
-18.21 %
(Jun 30 2021)   (Jun 30 2023)





Financial Statements
Strata Critical Medical Inc 's Assets $ 338 million SRTA's Balance sheet
Strata Critical Medical Inc 's Income $ -11 million Quarterly SRTA's Income Statement
SRTA's Income by Division See SRTA's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Sep 30 2021)
FY 2021
Y / Y Total Assets Change 30 % -8.31 % -11.63 % -10.02 % 23.59 %
Total Assets in million 325 250 273 309 343
Y / Y Net Income Change - - - - -
Net Income in million 41 -27 -56 -27 -40
Annual Return On Assets 12.7 % -10.91 % -20.54 % -8.82 % -11.66 %

SRTA's 5 Years Annual ROA >> Back to SRTA Management Effectiveness >> Compare SRTA ROA to its Competitors



Comment on SRTA's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 12.7 % compared to prior year, due to annual net income growth of % to $41.35 million, while value of Strata Critical Medical Inc 's overall assets grew just by 30 % to $325.47 million, compared to $325.47 a year before.


More Return On Assets Ratios
SRTA's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SRTA's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SRTA's Competitors
Subscribers only: Roa for Strata Critical Medical Inc 's Suppliers
Subscribers only: Return On Assets for SRTA's Customers

You may also want to know
SRTA's Roi SRTA's Inventory Turnover Ratio SRTA's Growth Rates SRTA's Dividend Comparisons
SRTA's Profitability Ratios SRTA's Asset Turnover Ratio SRTA's Dividend Growth
SRTA's Roe SRTA's Valuation Ratios SRTA's Financial Strength Ratios SRTA's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Meiragtx Holdings Plc  29.37 %
Indivior Pharmaceuticals Inc   28.21 %
Qhslab Inc   27.12 %
Adma Biologics Inc   26.58 %
Mettler toledo International Inc   24.86 %
Medpace Holdings Inc   24.84 %
Caredx Inc   24.81 %
Acadia Pharmaceuticals Inc   24.38 %
Eli Lilly And Company  21.97 %
Innoviva Inc   21.64 %
Vaxart Inc   20.85 %
Zevra Therapeutics Inc   20.39 %
Iradimed Corporation  20.36 %
Protalix Biotherapeutics inc   20.09 %
Pro dex Inc   19.87 %
Electromed Inc   19.39 %
United Therapeutics Corporation  17.98 %
Resmed Inc   17.80 %
Krystal Biotech Inc   17.65 %
Chemed Corporation  17.52 %
Zoetis Inc   17.19 %
Vertex Pharmaceuticals Inc  16.88 %
Halozyme Therapeutics Inc   16.55 %
Alnylam Pharmaceuticals Inc   15.76 %
Intuitive Surgical Inc   15.63 %
Healthcare Services Group Inc   15.21 %
Inspire Medical Systems inc   15.21 %
Dexcom Inc   14.87 %
Neurocrine Biosciences Inc   14.73 %
Entera Bio Ltd   14.60 %

Date modified: 2026-09-08T22:27:09+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.